论文信息 - COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 - 字舞流文

COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2

R. Corvò | G. Catalano | P. Franco | U. Ricardi | A. Magli | D. Genovesi | M. Pepa | M. Zaffaroni | G. Marvaso | M. Leonardi | B. Jereczek-Fossa | V. Tombolini | S. Pergolizzi | A. Merlotti | R. Pacelli | M. Gambacorta | M. Trovò | V. Donato | A. Filippi | S. Magrini | I. Meattini | A. Bruni | D. Musio | M. Mignogna | L. Marafioti | G. Iatì | M. Buglione di Monale e Bastia

[1] D. D'Souza,et al. Management of gynecologic cancer: Choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic , 2020, Radiotherapy and Oncology.

[2] F. Taghizadeh-Hesary,et al. Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus , 2020, Journal of Gastrointestinal Cancer.

[3] A. Lancia,et al. Radiotherapy in the era of COVID-19 , 2020, Expert review of anticancer therapy.

[4] Y. Lievens,et al. Effect of COVID-19 pandemic on practice in European radiation oncology centers☆ , 2020, Radiotherapy and Oncology.

[5] S. Peters,et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer , 2020, ESMO Open.

[6] Z. Liao,et al. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak , 2020, Lung Cancer.

[7] R. Orecchia,et al. Head and neck cancer radiotherapy amid COVID‐19 pandemic: Report from Milan, Italy , 2020, Head & neck.

[8] R. Corvò,et al. COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)☆ , 2020, Radiotherapy and Oncology.

[9] G. Mattiucci,et al. Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic – A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group☆ , 2020, Radiotherapy and Oncology.

[10] M. Gnant,et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer , 2020, ESMO Open.

[11] F. Lordick,et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer , 2020, ESMO Open.

[12] F. Lordick,et al. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer , 2020, ESMO Open.

[13] M. Scorsetti,et al. Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic , 2020, Radiotherapy and Oncology.

[14] A. Garden,et al. Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement , 2020, International Journal of Radiation Oncology*Biology*Physics.

[15] P. Iyengar,et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement , 2020, Radiotherapy and Oncology.

[16] R. Jagsi,et al. International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic , 2020, Clinical Oncology.

[17] V. Tombolini,et al. The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care☆ , 2020, Radiotherapy and Oncology.

[18] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.

[19] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[20] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.